NEW YORK and SUZHOU, China, Sept. 13, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases Innovative Drug Development Encouragement Pilot Program (the "Caring Plan-Extension", known...
Hence then, the article about accro bioscience announces inclusion of ac 101 tablets in the nmpa cde s caring plan extension pilot program for rare disease drug development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development )
Also on site :
- Patrick Stewart’s Lifelong Favorite ‘Comfort Food’ Was a Simple British Meal He’d Been Eating Since 1948
- 9-1-1 Volcano Crisis Ends With A Surprise Return — Plus, Buck Shows Eddie The Door: 'They're Definitely Not On The Same Page,' Says Oliver Stark
- Weakened Netanyahu spreads claims of malfeasance by Arab-led parties as his party claims Israel’s election was ‘stolen’